Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review

Hybrid Capture 2 testing can identify approximately 91% of women with residual or recurrent cervical intraepithelial neoplasia grade ≥ 2; however, approximately 30% of women would undergo colposcopy in follow-up evaluation.